[HTML][HTML] What nutraceuticals can do for Duchenne muscular dystrophy: lessons learned from amino acid supplementation in mouse models

B De Paepe - Biomedicines, 2023 - mdpi.com
… to 10 years treated with a combination of 2.5 g L-citrulline and 0.25 g metformin three times
a … , a randomized double-blinded placebo-controlled trial was conducted in another genetic …

[HTML][HTML] Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy

SR Casati, D Cervia, P Roux-Biejat, C Moscheni… - Cells, 2024 - mdpi.com
… DMD therapy can be divided into approaches targeting dystrophin … a randomized double-blind
clinical trial on 47 ambulant DMD patients revealed that overall l-citrulline plus metformin

[HTML][HTML] An update on Becker muscular dystrophy

V Straub, M Guglieri - Current Opinion in Neurology, 2023 - journals.lww.com
… [26] (as a single and combined treatment with L-citrulline) … A recent single centre open label
study was conducted to … The phase II, double-blind, placebo-controlled study enrolled 51 …

Biochemical markers of muscular dystrophy

IV Seniuk, B Yassine - 2023 - dspace.nuph.edu.ua
Duchenne Muscular Dystrophy (DMD) is the most common … in a singlecentre, randomized,
placebocontrolled trial in … 2016) Treatment with lcitrulline and metformin in Duchenne

[HTML][HTML] … and Urine after Derivatization with Pentafluoropropionic Anhydride and Its Application in Becker Muscular Dystrophy Patients Administered with Metformin, l …

S Baskal, A Bollenbach, B Henzi, P Hafner, D Fischer… - Molecules, 2022 - mdpi.com
… Then, patients received both drugs at the same time, ie, 3 × 500 mg metformin + 3 × 5 g l-citrulline
for 6 weeks of treatment. Analogous, blood, and urine samples were collected …

Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models

R Tsonaka, M Signorelli, E Sabir, A Seyer… - Human Molecular …, 2020 - academic.oup.com
… for the disease; however, the implementation of standards of care and … such as metformin
could be monitored by studying the … A follow-up double blind placebo controlled study was then …

Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, Y Jafari Abarghan… - International Journal …, 2021 - Taylor & Francis
… Therefore, metformin may be a possible beneficial therapeutic drug for the treatment of DMD
… -blinded, placebo-controlled trial with 186 patients. In this project, the patients were divided …

[HTML][HTML] Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia

XY Ma, FQ Chen - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
… , randomized, double-blind, placebo-controlled clinical trial … men treated using metformin,
or using metformin coupled with … , which are used to model Duchenne muscular dystrophy[63]. …

[HTML][HTML] Spatiotemporal mapping reveals regional gastrointestinal dysfunction in mdx dystrophic mice ameliorated by oral L-arginine supplementation

K Swiderski, R Bindon, J Trieu, T Naim… - Journal of …, 2020 - ncbi.nlm.nih.gov
… GI dysfunction in Duchenne muscular dystrophy has been … Alternatively, administration of
L-citrulline, a dietary amino acid … clinical scores in patients with Becker muscular dystrophy. …

Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan

M Kuraoka, Y Aoki, S Takeda - Experimental Animals, 2021 - jstage.jst.go.jp
Treatment with L-citrulline and metformin in duchenne muscular dystrophy: study
protocol for a singlecentre, randomised, placebo-controlled trial. …